J M Ferguson
Overview
Explore the profile of J M Ferguson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
458
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vakanski A, Ferguson J, Lee S
J Physiother Phys Rehabil
. 2017 Jan;
1(4).
PMID: 28111643
Objective: The objective of the proposed research is to develop a methodology for modeling and evaluation of human motions, which will potentially benefit patients undertaking a physical rehabilitation therapy (e.g.,...
2.
Iverson S, Brazil A, Ferguson J, Nelson K, Lautenbach E, Rankin S, et al.
Vet Microbiol
. 2015 Jan;
176(1-2):202-8.
PMID: 25623014
Methicillin-resistant strains of Staphylococcus aureus (MRSA), Staphylococcus pseudintermedius (MRSP), and other pathogenic staphylococci can cause infections in companion animals and humans. Identification of colonized animals is fundamental to research and...
3.
Dong G, Ferguson J, Duling A, Nicholas R, Zhang D, Rezvani K, et al.
Cell Mol Neurobiol
. 2011 Apr;
31(5):737-47.
PMID: 21452052
Huntington's disease (HD) is caused by an abnormal expansion of CAG trinucleotide repeats encoding polyglutamine (polyQ) in the first exon of the huntingtin (htt) gene. Despite considerable efforts, the pathogenesis...
4.
Thin L, Wong D, De Boer B, Ferguson J, Adams L, MacQuillan G, et al.
Intern Med J
. 2009 Aug;
40(10):710-5.
PMID: 19712200
Background: Hepatic epithelioid haemangioendothelioma (HEH) is a rare, low grade malignant neoplasm of endothelial origin which is difficult to diagnose and has a variable outcome. We review five HEH cases...
5.
Ferguson J, MENDELS J, Schwart G
Int Clin Psychopharmacol
. 2002 Mar;
17(2):45-51.
PMID: 11890185
Reboxetine is the first selective norepinephrine reuptake inhibitor (NRI) approved for the treatment of major depressive disorder (MDD). Although reboxetine has demonstrated efficacy for the treatment of depression, its effects...
6.
Le Bars P, Velasco F, Ferguson J, Dessain E, Kieser M, Hoerr R
Neuropsychobiology
. 2002 Jan;
45(1):19-26.
PMID: 11803237
Objective: To explore the treatment effect of EGb 761((R)) (EGb) in Alzheimer's disease depending on baseline severity. Methods: We applied stratification to the intent-to-treat data set collected during a 52-week,...
7.
Sanderson D, McLEOD J, Ferguson J
J Environ Radioact
. 2001 May;
53(3):411-22.
PMID: 11379066
No abstract available.
8.
Ferguson J, Shrivastava R, Stahl S, Hartford J, Borian F, Ieni J, et al.
J Clin Psychiatry
. 2001 Mar;
62(1):24-9.
PMID: 11235924
Background: Several different classes of antidepressants have been associated with sexual adverse effects. This double-blind, randomized trial compared the effects of nefazodone and sertraline on reemergence of sexual dysfunction in...
9.
Ferguson J
J Clin Psychiatry
. 2001 Mar;
62 Suppl 3:22-34.
PMID: 11229450
Sexual dysfunction has long been noted as both a symptom of depressive illness and as a side effect of many of the medications used to treat depression. Although most people...
10.